Trial Information

Summary: Twice Daily Inhaled Medication for COPD

The Clinical Research Center is enrolling subjects for a COPD research study of an investigational inhaled medication used for COPD/Emphysema. The study consists of 9 visits over approximately 1 year.

Eligible participants will be: 40 years of age or older and a current or former smoker. Qualified participants will receive study medication, pulmonary (lung) function tests, EKG's, laboratory tests, and study related physical exams at no cost.

All participants will receive rescue medication, such as albuterol, to use throughout the study. Compensation for participation is provided.

Patient Exclusion Criteria: Patients currently on Beta Blockers are not eligible.

Contact:

The Clinical Research Center, LLC
1040 North Mason, Suite 112
St. Louis, MO 63141
Telephone: 314-514-8509
Fax: 314-514-1244
Email:

Profile Page: The Clinical Research Center, LLC, St. Louis, MO

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 18, 2008 at 12:40:21 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA